Non-Small Cell Lung CancerDIAGNOSISLung cancer is becoming the most common cancer globally. In China, Lung cancer has become prevalent among preceding compared to present smokers. There are many treatments for lung cancer globally like Chemotherapy, Radiotherapy, Surgery, and Targeted therapy [1] [...
small-cell lung cancer (NSCLC), NADIM now confirms, in its final report, impressive 5-year clinical outcomes and that a pCR following neoadjuvant therapy translates into improved long-term survival. These data support the development of novel, personalized treatments for locally advanced resectable ...
In 2022, there were an estimated 2.1 million cases of non-small cell lung cancer worldwide. However, new treatments in the pipeline could be the key to reducing its prevalence. Download the free report from leading CRO Novotech to get the latest insights on global... Read more By ...
The treatments your doctor suggests will depend on how far your lungcancerhas spread. Causes Doctors aren't sure exactly what causes this disease. Many people who get it have smoked or been around smoke. Other things that makelung cancermore likely are: ...
Molecular targeted therapies and immunotherapies for non-small-cell lung cancer (NSCLC) have improved outcomes markedly over the past two decades. However, the vast majority of advanced NSCLCs become resistant to current treatments and eventually progress. In this Perspective, we discuss some of the...
Clinical Lung CancerO.Carpentier, L.Selvaggi, J.Jégu, A.Purohit, N.Prim, M.Velten, E.Quoix. (2015) Temporal trends and impact on survival of modern treatments in advanced non small cell lung cancer: a French population-based study. Clinical Lung Cancer /...
Research on biomarker-driven therapy and immune check-point blockade in non-small cell lung cancer (NSCLC) is rapidly evolving. The width and depth of clinical trials have also dramatically improved in an unprecedented speed. The personalized treatment p
One of the recent advances in lung cancer treatment has been the ability to treat some of these cancers by targeting tumors that have certain mutations that make them susceptible to these very specific treatments. Along with characterizing a tumor based on size and how far it has spread, oncolo...
Non-small-cell lung cancer is the most common type of lung cancer. Learn its causes, symptoms, and most common treatments.
Non-small cell lung cancer (NSCLC) is one of the most common malignancies in the world. Although extensive studies showed that luteolin exhibited antitumor effects against NSCLC, the mechanism has not been fully established. In the present study, we found that luteolin significantly reduced the exp...